Published:
Last updated:
NVT
ID
NL-OMON33078
Source
ToetsingOnline
Brief title
LY2165766 MAD study
Condition
- Schizophrenia and other psychotic disorders
Synonym
Schizophrenia
Research involving
Human
Sponsors and support
Primary sponsor
:
Chorus LRL (Division of Eli Lilly)
Source(s) of monetary or material Support
:
sponsor van dit onderzoek
Intervention
Keyword
:
LY2165766, Schizophrenia
Outcome measures
Primary outcome
NVT
Secondary outcome
NVT
Background summary
NVT
Study objective
NVT
Study design
NVT
Intervention
NVT
Study burden and risks
NVT
Public
Chorus LRL (Division of Eli Lilly)
Indianapolis
Indiana USA 46285
Nederland
Indianapolis
Indiana USA 46285
Nederland
Scientific
Chorus LRL (Division of Eli Lilly)
Indianapolis
Indiana USA 46285
Nederland
Indianapolis
Indiana USA 46285
Nederland
Listed location countries
Netherlands
Age
Adults (18-64 years)
Elderly (65 years and older)
Inclusion criteria
Healthy male 18 - 65
Healthy female 45 - 65 postmenopausal/sterilised
BMI 18.5 - 32
Exclusion criteria
Relevant medical history
Design
Study type
:
Interventional
Intervention model
:
Parallel
Allocation
:
Randomized controlled trial
Masking
:
Double blinded (masking used)
Control
:
Placebo
Primary purpose
:
Treatment
Recruitment
NL
Recruitment status
:
Recruitment stopped
Start date (anticipated)
:
Enrollment
:
20
Type
:
Actual
Approved WMO
Date
:
Application type
:
First submission
Review commission
:
BEBO: Stichting Beoordeling Ethiek Bio-Medisch Onderzoek (Assen)
Approved WMO
Date
:
Application type
:
First submission
Review commission
:
BEBO: Stichting Beoordeling Ethiek Bio-Medisch Onderzoek (Assen)
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
EudraCT | EUCTR2009-009376-12-NL |
CCMO | NL27347.056.09 |